(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from INPI

MOLÉCULAS DE ANTICORPO ANTI-SIGLEC-9

Em AnáliseInvention PatentPCT · EP2020082072

Application data

Number

112022009223

Type

Invention Patent

Filing

11/13/2020

Publication

08/02/2022

PCT

EP2020082072

Progress at the INPI

  1. Filing11/13/20
  2. Publication
  3. Examination
  4. Allowance
  5. Grant
  6. In force

The application was filed at the INPI on 11/13/2020. It awaits formal examination and publication in the RPI gazette.

Leave your contact and we will alert you

We track INPI publications and let you know as soon as this case moves.

We use your details only for this alert.

Latest action published by the INPI: 08/02/2022. We update with every new RPI gazette, published weekly.

Applicants and inventors

Applicants

MEMO THERAPEUTICS AG

CH

U. B. (pessoa física)

CH

Inventors

C. E. (pessoa física)

CH

H. L. (pessoa física)

CH

S. S. (pessoa física)

CH

Technical data

IPC Classification

Priority claims

EP

19209100.7 · 11/14/2019

EP

19209104.9 · 11/14/2019

Abstract

MOLÉCULAS DE ANTICORPO ANTI-SIGLEC-9. A presente invenção refere-se a moléculas de anticorpo anti-Siglec-9- ou seus fragmentos de ligação. Estas moléculas de anticorpo Anti-Siglec-9- ou fragmentos de ligação podem ser usados para tratar câncer, hepatite B crônica ou aguda.

Prosecution history

Publications in the Brazilian Industrial Property Gazette (RPI).

Notificação de entrada na fase nacional - PCT

#1.3

08/02/2022

RPI 2691

Alteração de dados cadastrais

#1.1

05/24/2022

RPI 2681

Patent monitoring

Track this patent in real time.

Receive alerts on INPI events, decisions, and expiry dates for your portfolio.